D2E0.F Adastra Holdings Ltd.

Healthcare Drug Manufacturers - Specialty & Generic Frankfurt Exchange
0.0840 EUR
Close of Nov 12, 2026
0.0730 0.1470
Market cap
EUR 470K
P/E
-
P/B
0.18x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2025.

Is D2E0.F undervalued?

Graham number

The Graham number of Adastra Holdings Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Adastra Holdings Ltd. fundamental analysis

No fundamental analysis for Adastra Holdings Ltd. yet.

Adastra Holdings Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Adastra Holdings Ltd.

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada. The company offers vape pens, wax, resin, infused pre-rolls, diamonds, and shatters under the Endgame brand. It also provides consulting and white label manufacturing. The company was formerly knowns as Phyto Extractions Inc. and changed its name to Adastra Holdings Ltd. in September 2021. Adastra Holdings Ltd. is headquartered in Langley, Canada.

Full company profile